From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
Number
Percent
HCC recurrence
 No
19
38.0
 Yes
31
62.0
Time (months)
 Min.–Max.
1.0–12.0
 Mean ± SD
3.34 ± 2.53
 Median
3.0